Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal.Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”), a targeted oncology company focused on developing cancer therapies…
Ikena Oncology’s $143.8 Million IPO


Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal.Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”), a targeted oncology company focused on developing cancer therapies…
…